Trial intelligence / Profile preview

Lidocaine for Postoperative Fatigue in TAPP Inguinal Hernia Repair

NCT07612839Not yet recruiting

Start
Sep 2026
Primary completion
Dec 2026
Countries
1
01

Overview

Randomised, triple-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative fatigue (2 arms). Primary endpoint: Multidimensional Fatigue Inventory-20 Physical Fatigue Subscale Score at Day 7. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative fatigue

Beyond the preview

Go deeper on NCT07612839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07612839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call